Act For NIH Act For NIH Act For NIH Act For NIH
  • WHAT’S AT STAKE
    • Medical Research Saves Lives
    • Top Things You Need To Know About The NIH
    • NIH: Improving Health Outcomes & Generating Breakthroughs
    • NIH’s Positive Return On Investment & Role In Lowering Costs
  • NIH FUNDING
    • NIH Funding Process
    • Fiscal Year 2026
    • Success Rates
  • NEWS & UPDATES
  • ABOUT
Act For NIH Act For NIH
  • WHAT’S AT STAKE
    • Medical Research Saves Lives
    • Top Things You Need To Know About The NIH
    • NIH: Improving Health Outcomes & Generating Breakthroughs
    • NIH’s Positive Return On Investment & Role In Lowering Costs
  • NIH FUNDING
    • NIH Funding Process
    • Fiscal Year 2026
    • Success Rates
  • NEWS & UPDATES
  • ABOUT

Ronald DePinho, M.D.

Ron DePinho is internationally recognized for basic and translational research in cancer, aging, and age-associated degenerative disorders. His research has yielded better methods of early cancer detection, improved cancer patient... read more →

The Hon. Eric Cantor

Eric Cantor is Vice Chairman and Managing Director of Moelis & Company as well as a member of the Moelis & Company Board of Directors. Mr. Cantor, who has more... read more →

James Allison, Ph.D.

Dr. James Allison is the Chair of the Department of Immunology, the Vivian L. Smith Distinguished Chair in Immunology, Director of the Parker Institute for Cancer Research, and the Executive... read more →
  • 1
  • 2

« Previous Page

ACT for NIH: Advancing Cures Today

300 New Jersey Avenue NW
Suite 300
Washington, D.C. 20001

Contact Us

connect@actfornih.org
@ACTforNIH
ACTforNIH

©2025 ACT for NIH. All rights reserved.